Real-life studies of biologics used in asthma patients: key differences and similarities to trials

Expert Review of Clinical Immunology
Enrico HefflerGiorgio Walter Canonica

Abstract

Introduction: The precision medicine approach that is now mandatory for severe asthma management includes the use of novel biologic agents blocking specific immunological mechanisms that are responsible for disease phenotypes and endotypes: monoclonal antibodies blocking IgE, IL-5 and IL-4/IL-13 immunological pathways are so far available. Areas covered: Clinical trials involving a large number of patients proved their efficacy in reducing asthma exacerbations, improving lung function and quality of life, and reducing the need for systemic corticosteroid treatment. Since biologics have been available for routine use, a series of real-life experiences on severe asthmatics treated with them have been published: these studies confirmed the beneficial effects in a real-world setting (effectiveness) of these drugs and showed novel aspects that were not covered by clinical trials, such as their effect on particular subgroup of patients, unexpected adverse events, and potential novel indications. Expert opinion: Both clinical trials and real-life experiences are needed to establish robust data on biologic agents for severe asthma, with real-life studies giving more broader insights on different aspects related to the biologics themsel...Continue Reading

References

Dec 23, 1999·The New England Journal of Medicine·H MilgromW J Metzger
Aug 10, 2001·The Journal of Allergy and Clinical Immunology·W BusseN Gupta
Sep 1, 2001·The European Respiratory Journal·M SolèrG Della Cioppa
Jun 2, 2010·The Journal of Allergy and Clinical Immunology·Roland KolbeckAnthony J Coyle
Mar 18, 2011·The New England Journal of Medicine·William W BusseChristine A Sorkness
Oct 2, 2012·The Journal of Allergy and Clinical Immunology·Philippe GevaertClaus Bachert
May 22, 2013·The New England Journal of Medicine·Sally WenzelGianluca Pirozzi
Dec 18, 2013·The European Respiratory Journal·Kian Fan ChungW Gerald Teague
Sep 10, 2014·The New England Journal of Medicine·Hector G OrtegaUNKNOWN MENSA Investigators
Sep 10, 2014·The New England Journal of Medicine·Elisabeth H BelUNKNOWN SIRIUS Investigators
May 30, 2015·The European Respiratory Journal·Antoine DeschildreJocelyne Just
Feb 3, 2016·JAMA : the Journal of the American Medical Association·Claus BachertE Rand Sutherland
Sep 17, 2016·International Archives of Allergy and Immunology·Diego BagnascoGiorgio Walter Canonica
Oct 4, 2016·The New England Journal of Medicine·Eric L SimpsonUNKNOWN SOLO 1 and SOLO 2 Investigators
Jan 11, 2017·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Manali MukherjeeParameswaran Nair
Feb 23, 2017·Pharmacotherapy·Alessandro TonacciSebastiano Gangemi
Mar 10, 2017·Expert Review of Clinical Immunology·Namita A GandhiNeil M H Graham
Mar 30, 2017·The Journal of Allergy and Clinical Immunology. in Practice·Abdulaziz AlhossanIvo Abraham
May 23, 2017·The New England Journal of Medicine·Parameswaran NairUNKNOWN ZONDA Trial Investigators
Dec 1, 2017·Current Opinion in Allergy and Clinical Immunology·Giorgio W CanonicaEnrico Heffler
Dec 8, 2017·Current Respiratory Medicine Reviews·Amelia LicariUNKNOWN Omalizumab in Childhood Asthma Italian Study Group
Jan 23, 2018·The Journal of Allergy and Clinical Immunology·Steven F WeinsteinAriel Teper
May 22, 2018·The New England Journal of Medicine·Mario CastroAriel Teper
May 22, 2018·The New England Journal of Medicine·Klaus F RabeAriel Teper
Aug 9, 2018·Allergy, Asthma & Immunology Research·Manali Mukherjee, Parameswaran Nair
Sep 5, 2018·The Journal of Allergy and Clinical Immunology. in Practice·Lakmini BulathsinhalaDavid Price
Sep 6, 2018·Therapeutic Advances in Chronic Disease·Lieneke F M AriënsMarjolein S de Bruin-Weller
Oct 28, 2018·The Journal of Allergy and Clinical Immunology. in Practice·Enrico HefflerUNKNOWN SANI Network
Nov 10, 2018·The World Allergy Organization Journal·Giorgio Walter CanonicaUNKNOWN PROXIMA study centers
Dec 7, 2018·BioMed Research International·Diego BagnascoGiovanni Passalacqua
Dec 18, 2018·The World Allergy Organization Journal·Diego BagnascoGiovanni Passalacqua
Jan 1, 2019·Pulmonary Pharmacology & Therapeutics·Carlo LombardiGiovanni Passalacqua
Jan 25, 2019·The Journal of Allergy and Clinical Immunology. in Practice·Luis A Pérez de LlanoFrancisco J Alvarez-Gutiérrez
Feb 8, 2019·European Clinical Respiratory Journal·Andreas HeddiniChrister Janson

❮ Previous
Next ❯

Citations

Nov 7, 2019·Current Opinion in Allergy and Clinical Immunology·Diego BagnascoGiovanni Passalacqua
Dec 3, 2020·Respiratory Medicine·Anne Sofie BjerrumJohannes Martin Schmid
Dec 29, 2020·Current Opinion in Allergy and Clinical Immunology·Giacomo MalipieroGiovanni Paoletti
Oct 2, 2020·The World Allergy Organization Journal·Giorgio Walter CanonicaUNKNOWN SANI (Severe Asthma Network Italy)
Mar 25, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Zorica LazicVojislav Cupurdija
Jun 1, 2021·Expert Review of Respiratory Medicine·Maria De FilippoGian Luigi Marseglia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.